Caution about ketoacidosis, UTIs, and other serious ADRs with the SGLT-2s

More warnings for the SGLT2 inhibitors (Invokana, etc) will increase concerns about their safety.

These "flozins" are popular because they have a low risk of hypoglycemia...lead to modest weight loss...and can lower BP.

Plus Jardiance (empagliflozin) has CV benefits including a reduced risk of cardiovascular death and heart failure hospitalizations.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote